Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Coronavirus, Strain
85 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
85
Total Reports
14
Deaths Reported
1650.0%
Death Rate
Active Ingredients
Canine Adenovirus Type 2, Strain Manhattan, 12-13-76; Canine Coronavirus, Strain
Administration Routes
Subcutaneous
Species Affected
Dog 85
Most Affected Breeds
Retriever - Labrador 12
Chihuahua 9
Terrier - Yorkshire 8
Rottweiler 4
Beagle 3
Pinscher - Miniature 3
Weimaraner 3
Retriever - Golden 3
Terrier - Jack Russell 3
Boxer (German Boxer) 3
Most Reported Reactions
Lethargy (see also Central nervous system depression in 'Neurological') 23
Vomiting 23
Diarrhoea 17
Other abnormal test result NOS 15
Elevated serum alkaline phosphatase (SAP) 10
Fever 9
Anorexia 9
Leucocytosis NOS 9
Death by euthanasia 8
Hypoalbuminaemia 8
Lack of efficacy - NOS 8
Decreased appetite 8
Outcome Breakdown
Ongoing
45 (50.6%)
Recovered/Normal
26 (29.2%)
Euthanized
8 (9.0%)
Died
6 (6.7%)
Outcome Unknown
4 (4.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.